Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study aims to verify the effectiveness of Trafermin (recombinant human basic fibroblast
growth factor) in stimulating regeneration of periodontal tissue lost by periodontitis and to
evaluate the safety of such stimulation.